The World Health Organization (WHO) on Thursday issued a medical product alert on the release of three batches of falsified semaglutides – the type of medicines primarily used to treat type 2 diabetes and obesity in some countries.
from UN News - Global perspective Human stories https://ift.tt/rWRJeQn
via IFTTT
from UN News - Global perspective Human stories https://ift.tt/rWRJeQn
via IFTTT